시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 천장관절염 치료 시장 보고서(2025년)
Sacroiliitis Treatment Global Market Report 2025
상품코드 : 1769739
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,310,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,121,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,932,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

천장관절염 치료 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 이러한 성장은 혁신적인 치료법을 위한 연구개발(R&D)에 대한 투자 확대, 만성 통증 관리를 위한 원격 의료 서비스의 사용 증가, 자가면역 질환 발생 증가, 특정 경로를 표적으로 하는 생물학적 치료법에 대한 광범위한 접근성, 개인 맞춤형 의료 치료에 대한 강조 증가로 뒷받침될 것입니다.

관절 장애 증가는 천장관절염 치료 시장의 성장을 가속할 것으로 예측됩니다. 인구가 고령화됨에 따라 관절의 마모가 자연스럽게 증가하여 골관절염 및 기타 퇴행성 관절 질환과 같은 질환의 유병률이 높아집니다. 천장관절염 치료는 천장 관절의 염증과 통증을 완화하여 가동성과 관절 기능을 향상시키고 증상을 완화합니다. 예를 들어 2024년 6월 호주 보건복지연구소(Australian Institute of Health and Welfare)는 변형성 관절증이 2022년에 추정 210만명의 호주인(8.3%)에 영향을 주었으며, 그 중 여성의 10%, 남성의 6.1%가 이환되고 있다고 보고했습니다.

천장관절염 치료 시장의 기업은 혁신적인 치료법의 도입을 촉진하고 시장 접근을 확보하고 경쟁력을 강화하기 위해 약사 승인을 우선하고 있습니다. Spinal Simplicity는 Liberty-SI Lateral Implant System의 FDA 510(k) 인가를 취득했습니다. 이 시스템은 천장 관절 파괴나 퇴행성 천장 관절염 등의 환자의 천장 관절 고정용으로 설계된 저침습 장치입니다. 이 임플란트들은 중앙에 나사산이 있는 몸체를 가지고 있으며, 펼쳐지는 날개와 압박 요소를 포함합니다. 다양한 크기로 제공되며, 하이드록시아파타이트(hydroxyapatite)로 코팅되어 골 통합(bone integration)을 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Sacroiliitis treatment refers to the healthcare interventions used to address inflammation in one or both of the sacroiliac joints, which connect the lower spine to the pelvis. This condition often leads to pain in the lower back, buttocks, or legs and is frequently linked to inflammatory disorders such as ankylosing spondylitis. The main objective of sacroiliitis treatment is to alleviate inflammation, reduce pain, and improve mobility.

Key treatment options for sacroiliitis include medications, joint injections, joint fusion surgery, radiofrequency denervation, and electrical stimulation. Medications primarily involve nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics that are effective in easing inflammation and pain in the sacroiliac region. Diagnosis involves various methods such as imaging tests, physical exams, and laboratory diagnostics. These treatments are delivered through oral, injectable, or topical routes and are utilized in diverse settings including hospitals, specialty clinics, ambulatory surgical centers, and home care facilities.

The sacroiliitis treatment market research report is one of a series of new reports from The Business Research Company that provides sacroiliitis treatment market statistics, including sacroiliitis treatment industry global market size, regional shares, competitors with a sacroiliitis treatment market share, detailed sacroiliitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the sacroiliitis treatment industry. This sacroiliitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sacroiliitis treatment market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.77 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. This growth during the historical period was fueled by the increasing prevalence of lower back pain, a growing emphasis on early diagnosis, a surge in pelvic injuries from sports, greater use of advanced imaging methods, and a heightened preference for minimally invasive treatment options.

The sacroiliitis treatment market size is expected to see strong growth in the next few years. It will grow to $2.33 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The projected growth will be supported by greater investment in R&D for innovative therapies, the rising use of telehealth services in managing chronic pain, increasing occurrences of autoimmune disorders, broader access to biologic therapies targeting specific pathways, and a growing emphasis on personalized medical treatments. Prominent trends anticipated in this period include innovations in targeted drug delivery, emergence of customized treatment regimens, progress in regenerative therapy solutions, improvements in robotic-assisted surgical techniques, and the evolution of integrated treatment protocols.

The rising number of joint disorders is expected to drive the growth of the sacroiliitis treatment market. Joint disorders, which include conditions causing pain, inflammation, stiffness, and limited movement in the joints, are often due to factors such as aging, injury, autoimmune diseases, or infections. As populations age, there is a natural increase in wear and tear on joints, leading to a greater prevalence of conditions like osteoarthritis and other degenerative joint diseases. Sacroiliitis treatment plays a crucial role in managing joint disorders by reducing inflammation and pain in the sacroiliac joints, thereby improving mobility and joint function, which helps alleviate symptoms and prevent further damage. For example, in June 2024, the Australian Institute of Health and Welfare reported that osteoarthritis affected an estimated 2.1 million Australians (8.3%) in 2022, including 10% of women and 6.1% of men. This growing incidence of joint disorders is contributing to the expansion of the sacroiliitis treatment market.

Companies in the sacroiliitis treatment market are prioritizing regulatory approvals to facilitate the introduction of innovative therapies, ensure market access, and reinforce their competitive positions. Regulatory approvals signify formal authorization by government health agencies, confirming that a medical treatment is safe and effective for public use. In December 2023, Spinal Simplicity, a US-based medical equipment manufacturer, received FDA 510(k) clearance for its Liberty-SI Lateral Implant System. This system is a minimally invasive device designed for sacroiliac joint fusion in patients with conditions such as sacroiliac disruptions and degenerative sacroiliitis. It employs a lateral approach by inserting one or two titanium implants through the ilium and across the SI joint into the sacrum, providing stabilization and fusion. These implants have a central threaded body with deployable wings and compressive elements, come in various sizes, and are coated with hydroxyapatite to enhance bone integration. The system is designed to be less invasive, potentially shortening anesthesia time and improving patient outcomes.

In November 2023, Nevro Corp., a US-based medical device company focused on pain management solutions, acquired Vyrsa Technologies for an undisclosed amount. This acquisition is intended to enhance Nevro's portfolio of minimally invasive treatments and accelerate the adoption and development of Vyrsa's advanced spinal technologies by leveraging Nevro's commercial infrastructure and clinical expertise. Vyrsa Technologies is a US-based medical device firm that provides a minimally invasive treatment option for sacroiliitis, specifically concentrating on sacroiliac joint fusion.

Major players in the sacroiliitis treatment market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Biogen Inc., Sandoz Group AG, UCB S.A., Hikma Pharmaceuticals PLC, Samsung Bioepis Co. Ltd., Lupin Limited, Zydus Lifesciences Limited, Celltrion Healthcare Co. Ltd., Torrent Pharmaceuticals Limited, Globus Medical, Fortis Healthcare, Orthofix Medical Inc., Coherus BioSciences Inc., and SI-BONE Inc.

North America was the largest region in the sacroiliitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sacroiliitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sacroiliitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sacroiliitis treatment market includes revenues earned by entities by providing services, such as anti-inflammatory medications, pharmacological treatment, physical therapy, interventional pain management, surgical services, and chiropractic and osteopathic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sacroiliitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sacroiliitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for sacroiliitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sacroiliitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Sacroiliitis Treatment Market Characteristics

3. Sacroiliitis Treatment Market Trends And Strategies

4. Sacroiliitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sacroiliitis Treatment Growth Analysis And Strategic Analysis Framework

6. Sacroiliitis Treatment Market Segmentation

7. Sacroiliitis Treatment Market Regional And Country Analysis

8. Asia-Pacific Sacroiliitis Treatment Market

9. China Sacroiliitis Treatment Market

10. India Sacroiliitis Treatment Market

11. Japan Sacroiliitis Treatment Market

12. Australia Sacroiliitis Treatment Market

13. Indonesia Sacroiliitis Treatment Market

14. South Korea Sacroiliitis Treatment Market

15. Western Europe Sacroiliitis Treatment Market

16. UK Sacroiliitis Treatment Market

17. Germany Sacroiliitis Treatment Market

18. France Sacroiliitis Treatment Market

19. Italy Sacroiliitis Treatment Market

20. Spain Sacroiliitis Treatment Market

21. Eastern Europe Sacroiliitis Treatment Market

22. Russia Sacroiliitis Treatment Market

23. North America Sacroiliitis Treatment Market

24. USA Sacroiliitis Treatment Market

25. Canada Sacroiliitis Treatment Market

26. South America Sacroiliitis Treatment Market

27. Brazil Sacroiliitis Treatment Market

28. Middle East Sacroiliitis Treatment Market

29. Africa Sacroiliitis Treatment Market

30. Sacroiliitis Treatment Market Competitive Landscape And Company Profiles

31. Sacroiliitis Treatment Market Other Major And Innovative Companies

32. Global Sacroiliitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sacroiliitis Treatment Market

34. Recent Developments In The Sacroiliitis Treatment Market

35. Sacroiliitis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기